These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 36307192)
41. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients. JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815 [TBL] [Abstract][Full Text] [Related]
42. Integration analysis of long non-coding RNA (lncRNA) role in tumorigenesis of colon adenocarcinoma. Poursheikhani A; Abbaszadegan MR; Nokhandani N; Kerachian MA BMC Med Genomics; 2020 Jul; 13(1):108. PubMed ID: 32727450 [TBL] [Abstract][Full Text] [Related]
43. Identification and validation of calcium extrusion-related genes prognostic signature in colon adenocarcinoma. Jin M; Yin C; Yang J; Yang X; Wang J; Zhu J; Yuan J PeerJ; 2024; 12():e17582. PubMed ID: 39006025 [TBL] [Abstract][Full Text] [Related]
44. Combination of lysine-specific demethylase 6A (KDM6A) and mismatch repair (MMR) status is a potential prognostic factor in colorectal cancer. Chen X; Yang Z; Feng J; Duan T; Pan T; Yan L; Jin T; Xiang Y; Zhang M; Chen P; Wang W; Zhang R; Chen B; Zhao L; Xie T; Sui X Cancer Med; 2021 Jan; 10(1):317-324. PubMed ID: 33174323 [TBL] [Abstract][Full Text] [Related]
45. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms. Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423 [TBL] [Abstract][Full Text] [Related]
46. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment. Lin A; Gu T; Hu X; Zhang J; Luo P J Immunol Res; 2022; 2022():8179799. PubMed ID: 35707003 [TBL] [Abstract][Full Text] [Related]
47. Relationship between ATOH1 and tumor microenvironment in colon adenocarcinoma patients with different microsatellite instability status. Mou W; Zhu L; Yang T; Lin A; Lyu Q; Guo L; Liu Z; Cheng Q; Zhang J; Luo P Cancer Cell Int; 2022 Jul; 22(1):229. PubMed ID: 35836254 [TBL] [Abstract][Full Text] [Related]
48. Development and validation of a risk prediction model and nomogram for colon adenocarcinoma based on methylation-driven genes. Zhu L; Sun H; Tian G; Wang J; Zhou Q; Liu P; Tang X; Shi X; Yang L; Liu G Aging (Albany NY); 2021 Jun; 13(12):16600-16619. PubMed ID: 34182539 [TBL] [Abstract][Full Text] [Related]
49. A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer. Liu Z; Liu Z; Zhou X; Lu Y; Yao Y; Wang W; Lu S; Wang B; Li F; Fu W Hum Genomics; 2022 Feb; 16(1):5. PubMed ID: 35109912 [TBL] [Abstract][Full Text] [Related]
50. Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs. Hao Z; Liang P; He C; Sha S; Yang Z; Liu Y; Shi J; Zhu Z; Chang Q BMC Bioinformatics; 2022 Oct; 23(1):435. PubMed ID: 36258178 [TBL] [Abstract][Full Text] [Related]
51. An integrated bioinformatic investigation of mitochondrial energy metabolism genes in colon adenocarcinoma followed by preliminary validation of CPT2 in tumor immune infiltration. Cao Z; Lin J; Fu G; Niu L; Yang Z; Cai W Front Immunol; 2022; 13():959967. PubMed ID: 36177002 [TBL] [Abstract][Full Text] [Related]
52. Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma. Huang H; Lu L; Li Y; Chen X; Li M; Yang M; Huang X PeerJ; 2023; 11():e16477. PubMed ID: 38025763 [TBL] [Abstract][Full Text] [Related]
53. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma. Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774 [TBL] [Abstract][Full Text] [Related]
54. Liu L; Jia S; Jin X; Zhu S; Zhang S DNA Cell Biol; 2021 Sep; 40(9):1158-1166. PubMed ID: 34415792 [TBL] [Abstract][Full Text] [Related]
55. Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer. Lin H; Cao B Dis Markers; 2022; 2022():3592990. PubMed ID: 35937946 [TBL] [Abstract][Full Text] [Related]
56. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma. Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K Front Immunol; 2023; 14():1093974. PubMed ID: 36949947 [TBL] [Abstract][Full Text] [Related]
57. Identification of a novel glycolysis-related gene signature for predicting the survival of patients with colon adenocarcinoma. Yi K; Wu J; Tang X; Zhang Q; Wang B; Wang F Scand J Gastroenterol; 2022 Feb; 57(2):214-221. PubMed ID: 34644216 [TBL] [Abstract][Full Text] [Related]
58. Identification of fatty acid metabolism-related lncRNAs in the prognosis and immune microenvironment of colon adenocarcinoma. Wu S; Gong Y; Chen J; Zhao X; Qing H; Dong Y; Li S; Li J; Wang Z Biol Direct; 2022 Jul; 17(1):19. PubMed ID: 35902970 [TBL] [Abstract][Full Text] [Related]
59. Glutathione peroxidase 2: A key factor in the development of microsatellite instability in colon cancer. Cui Z; Xu L; Wu H; Wang M; Lu L; Wu S Pathol Res Pract; 2023 Mar; 243():154372. PubMed ID: 36796200 [TBL] [Abstract][Full Text] [Related]
60. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma. Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]